GlaxoSmithKline names new CEO

Posted online September 20, 2016 | 10:55 am

British drugmaker GlaxoSmithKline today announced the promotion of Emma Walmsley, its head of consumer health care, to CEO after an internal and external search.

Walmsley becomes the first woman to lead a global pharmaceutical company and the seventh to run a business in Britain's FTSE 100 index.

Walmsley, 47, succeeds Andrew Witty, who plans to retire on March 31, 2017.

Read more from Reuters.

Comments

No comments on this story |

Please log in to add your comment

Prater's nomination for State Board of Education pulled by Kehoe

Editors' Pick

Open for Business: Dame Chiropractic

Dame Chiropractic LLC emerged as the new name of Harshman Chiropractic Clinic LLC with the purchase of the business; Leo Kim added a second venture, Keikeu LLC, to 14 Mill Market; and Mercy Springfield Communities opened its second primary care clinic in Ozark.

Most Read